WH-4-023

Catalog No.S7565 Synonyms: KIN001-112, KIN112

WH-4-023 Chemical Structure

Molecular Weight(MW): 568.67

WH-4-023 is a potent and orally active Lck/Src inhibitor with IC50s of 2 nM and 6 nM in cell-free assays, respectively. Exhibits >300-fold selectivity against p38α and KDR. Also potently inhibits SIK (IC50 values are 10, 22 and 60 nM for SIK 1, 2 and 3 respectively) and displays selectivity over a range of closely related kinases.

Size Price Stock Quantity  
USD 147 In stock
USD 477 In stock
USD 997 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Purity & Quality Control

Choose Selective Src Inhibitors

Biological Activity

Description WH-4-023 is a potent and orally active Lck/Src inhibitor with IC50s of 2 nM and 6 nM in cell-free assays, respectively. Exhibits >300-fold selectivity against p38α and KDR. Also potently inhibits SIK (IC50 values are 10, 22 and 60 nM for SIK 1, 2 and 3 respectively) and displays selectivity over a range of closely related kinases.
Targets
Lck [1]
(Cell-free assay)
Src [1]
(Cell-free assay)
2 nM 6 nM
In vitro

WH-4-023 shows little activity on p38 and KDR. [1]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
human EM-2 cell MkX6S5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? M1PLSGlvcGmkaYTpc44hd2ZiaIXtZY4hTU1vMjDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG|c3H5MEBKSzVyPUOuPVFmNTB6IN88US=> NFe3VI1USU6JRWK=
human LAMA-84 cell M{C4cmdzd3e2aDDpcohq[mm2aX;uJIF{e2G7 NVnIcXhjUW6qaXLpeIlwdiCxZjDoeY1idiCOQV3BMVg1KGOnbHyg[5Jwf3SqIHnuJIEh[2WubDD2bYFjcWyrdImgZZN{[XluIFnDOVA:Oy55OHWtNFYh|ryP NIfwTWVUSU6JRWK=
human EoL-1-cell cell NFfLc5FIem:5dHigbY5pcWKrdHnvckBie3OjeR?= NHS0VXdKdmirYnn0bY9vKG:oIHj1cYFvKEWxTD2xMYNmdGxiY3XscEBoem:5dHigbY4h[SClZXzsJJZq[WKrbHn0fUBie3OjeTygTWM2OD17LkWx[U0xPiEQvF2= MlLXV2FPT0WU
human MEG-01 cell Mn3vS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? M2HGVGlvcGmkaYTpc44hd2ZiaIXtZY4hVUWJLUCxJINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZktKEmFNUC9NU43O2VvMEWg{txO Mm\rV2FPT0WU
human CTV-1 cell MoHHS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? NXn5fZd1UW6qaXLpeIlwdiCxZjDoeY1idiCFVG[tNUBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NCCLQ{WwQVMvOTinLUC1JO69VQ>? MnfFV2FPT0WU
human BL-70 cell NWq2eGVLT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= M4flUWlvcGmkaYTpc44hd2ZiaIXtZY4hSkxvN{CgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfUwhUUN3ME20Mlcz\S1yNTFOwG0> MXPTRW5ITVJ?
human K-562 cell Ml3RS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? NHHOSmZKdmirYnn0bY9vKG:oIHj1cYFvKEtvNU[yJINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZktKEmFNUC9NE4xODBzNkKg{txO NYLpOJZIW0GQR1XS
human BV-173 cell NHzVRXBIem:5dHigbY5pcWKrdHnvckBie3OjeR?= MnPYTY5pcWKrdHnvckBw\iCqdX3hckBDXi1zN{OgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfUwhUUN3ME2wMlAxODVzNDFOwG0> NXPKdHY3W0GQR1XS
human DOHH-2 cell NFW1cmdIem:5dHigbY5pcWKrdHnvckBie3OjeR?= MkLDTY5pcWKrdHnvckBw\iCqdX3hckBFV0iKLUKgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfUwhUUN3ME2wMlAxODV7NzFOwG0> NXzQNXNVW0GQR1XS
human A704 cell NFjMe45Iem:5dHigbY5pcWKrdHnvckBie3OjeR?= M1XUUGlvcGmkaYTpc44hd2ZiaIXtZY4hSTdyNDDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG|c3H5MEBKSzVyPUCuNFAyOjdizszN NWC2OJN{W0GQR1XS
human NCI-SNU-16 cell M2nNemdzd3e2aDDpcohq[mm2aX;uJIF{e2G7 MUfJcohq[mm2aX;uJI9nKGi3bXHuJG5EUS2VTmWtNVYh[2WubDDndo94fGhiaX6gZUBk\WyuII\pZYJqdGm2eTDhd5NigSxiSVO1NF0xNjBzNUeyJO69VQ>? MnT2V2FPT0WU
human LC-2-ad cell MlLpS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? MWDJcohq[mm2aX;uJI9nKGi3bXHuJGxENTJvYXSgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfUwhUUN3ME2wMlAzODN|IN88US=> M3LOWXNCVkeHUh?=
human LB2518-MEL cell MXXHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? NXL2PG9wUW6qaXLpeIlwdiCxZjDoeY1idiCOQkK1NVguVUWOIHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO|YYmsJGlEPTB;MD6wOFY3PyEQvF2= NXOwSWxNW0GQR1XS
human D-336MG cell M1HPXGdzd3e2aDDpcohq[mm2aX;uJIF{e2G7 MYTJcohq[mm2aX;uJI9nKGi3bXHuJGQuOzN4TVegZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfUwhUUN3ME2wMlA1PjhzIN88US=> MXfTRW5ITVJ?
human LB996-RCC cell NYLpWoV{T3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= M1TSWGlvcGmkaYTpc44hd2ZiaIXtZY4hVEJ7OU[tVmNEKGOnbHyg[5Jwf3SqIHnuJIEh[2WubDD2bYFjcWyrdImgZZN{[XluIFnDOVA:OC5yNU[2PEDPxE1? NGL3UW1USU6JRWK=
human Becker cell MnLjS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? M{Ds[GlvcGmkaYTpc44hd2ZiaIXtZY4hSmWla3XyJINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZktKEmFNUC9NE4xPjN6MTFOwG0> Ml3zV2FPT0WU
human LB1047-RCC cell NXLDTWpNT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= MmjqTY5pcWKrdHnvckBw\iCqdX3hckBNSjFyNEetVmNEKGOnbHyg[5Jwf3SqIHnuJIEh[2WubDD2bYFjcWyrdImgZZN{[XluIFnDOVA:OC5yN{W5NkDPxE1? MmHWV2FPT0WU
human KS-1 cell MWfHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? MXTJcohq[mm2aX;uJI9nKGi3bXHuJGtUNTFiY3XscEBoem:5dHigbY4h[SClZXzsJJZq[WKrbHn0fUBie3OjeTygTWM2OD1yLkC3O|U5KM7:TR?= M3Pp[nNCVkeHUh?=
human MPP-89 cell NUfIdXdDT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= NGn0cGpKdmirYnn0bY9vKG:oIHj1cYFvKE2SUD24PUBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NCCLQ{WwQVAvODh{Mkmg{txO MX\TRW5ITVJ?
human RXF393 cell MYLHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? NEPEWFZKdmirYnn0bY9vKG:oIHj1cYFvKFK[RkO5N{Bk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NCCLQ{WwQVAvOTB4M{Og{txO MkjNV2FPT0WU
LB831-BLC cell Mnq3S5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? NGq1SIJKdmirYnn0bY9vKG:oIHj1cYFvKEyEOEOxMWJNSyClZXzsJIdzd3e2aDDpckBiKGOnbHygeoli[mmuaYT5JIF{e2G7LDDJR|UxRTBwMUK3NVUh|ryP MUDTRW5ITVJ?
HUTU-80 cell NH7WdFRIem:5dHigbY5pcWKrdHnvckBie3OjeR?= MV;Jcohq[mm2aX;uJI9nKGi3bXHuJGhWXFVvOECgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfUwhUUN3ME2wMlE4PTJ7IN88US=> NHPFcYFUSU6JRWK=
A498 cell MYDHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? MXvJcohq[mm2aX;uJI9nKGi3bXHuJGE1QThiY3XscEBoem:5dHigbY4h[SClZXzsJJZq[WKrbHn0fUBie3OjeTygTWM2OD1yLkG4PVQ2KM7:TR?= NGHVUGRUSU6JRWK=
MZ1-PC cell M3Xpcmdzd3e2aDDpcohq[mm2aX;uJIF{e2G7 NHnD[4FKdmirYnn0bY9vKG:oIHj1cYFvKE2cMT3QR{Bk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NCCLQ{WwQVAvOjJ5MU[g{txO MmnjV2FPT0WU
TE-8 cell M2TmPWdzd3e2aDDpcohq[mm2aX;uJIF{e2G7 MlPjTY5pcWKrdHnvckBw\iCqdX3hckBVTS16IHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO|YYmsJGlEPTB;MD6yN|kzPCEQvF2= M3;aU3NCVkeHUh?=
MFH-ino cell  M2faW2dzd3e2aDDpcohq[mm2aX;uJIF{e2G7 M4DFe2lvcGmkaYTpc44hd2ZiaIXtZY4hVU[KLXnuc{Bk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NCCLQ{WwQVAvOjN7MkWg{txO NXXCUo5qW0GQR1XS
TE-15 cell M2XjfWdzd3e2aDDpcohq[mm2aX;uJIF{e2G7 MUDJcohq[mm2aX;uJI9nKGi3bXHuJHRGNTF3IHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO|YYmsJGlEPTB;MD6yOFI4PiEQvF2= MY\TRW5ITVJ?
NTERA-S-cl-D1 cell NHLWVZBIem:5dHigbY5pcWKrdHnvckBie3OjeR?= M3LwfWlvcGmkaYTpc44hd2ZiaIXtZY4hVlSHUlGtV{1kdC2GMTDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG|c3H5MEBKSzVyPUCuNlg5PTVizszN MX\TRW5ITVJ?
COLO-829 cell MW\Hdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? NUjZOXJNUW6qaXLpeIlwdiCxZjDoeY1idiCFT1zPMVgzQSClZXzsJIdzd3e2aDDpckBiKGOnbHygeoli[mmuaYT5JIF{e2G7LDDJR|UxRTBwM{GyNVIh|ryP NIP5dlhUSU6JRWK=
SW684 cell NEj0ZpNIem:5dHigbY5pcWKrdHnvckBie3OjeR?= MkT3TY5pcWKrdHnvckBw\iCqdX3hckBUXzZ6NDDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG|c3H5MEBKSzVyPUCuN|I2QDhizszN NWjCW2lpW0GQR1XS
OS-RC-2 cell Mn7CS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? MonzTY5pcWKrdHnvckBw\iCqdX3hckBQWy2UQz2yJINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZktKEmFNUC9NE4{PTBzMTFOwG0> MYHTRW5ITVJ?
IST-MES1 cell NVPqUG82T3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= M1nlZmlvcGmkaYTpc44hd2ZiaIXtZY4hUVOWLV3FV|Eh[2WubDDndo94fGhiaX6gZUBk\WyuII\pZYJqdGm2eTDhd5NigSxiSVO1NF0xNjN3N{KzJO69VQ>? NWi3[FFvW0GQR1XS
SNB75 cell MlHRS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? NXPMS2h2UW6qaXLpeIlwdiCxZjDoeY1idiCVTlK3OUBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NCCLQ{WwQVAvOzV5N{Sg{txO MnL3V2FPT0WU
SW954 cell NFjOOY1Iem:5dHigbY5pcWKrdHnvckBie3OjeR?= MXfJcohq[mm2aX;uJI9nKGi3bXHuJHNYQTV2IHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO|YYmsJGlEPTB;MD6zO|E3OyEQvF2= NEC4cnZUSU6JRWK=
RCC10RGB cell NUfrboo{T3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= MlXJTY5pcWKrdHnvckBw\iCqdX3hckBTS0NzMGLHRkBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NCCLQ{WwQVAvPDJ4M{Gg{txO Ml3MV2FPT0WU
VA-ES-BJ cell NIjWOYRIem:5dHigbY5pcWKrdHnvckBie3OjeR?= MV;Jcohq[mm2aX;uJI9nKGi3bXHuJHZCNUWVLVLKJINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZktKEmFNUC9NE41PjJ4IN88US=> NEjY[I5USU6JRWK=
NCI-H1648 cell MXTHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? MlPtTY5pcWKrdHnvckBw\iCqdX3hckBPS0lvSEG2OFgh[2WubDDndo94fGhiaX6gZUBk\WyuII\pZYJqdGm2eTDhd5NigSxiSVO1NF0xNjVzNUiyJO69VQ>? MYfTRW5ITVJ?
PF-382 cell MV3Hdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? NFTscHNKdmirYnn0bY9vKG:oIHj1cYFvKFCILUO4NkBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NCCLQ{WwQVAvPzB5NkOg{txO NH6wVIdUSU6JRWK=
human Daudi cell NWHKWHNFT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= NX\iT3FmUW6qaXLpeIlwdiCxZjDoeY1idiCGYYXkbUBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NCCLQ{WwQVAvPzF2MUGg{txO MmXCV2FPT0WU
SW982 cell NVr5eHV7T3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= MVvJcohq[mm2aX;uJI9nKGi3bXHuJHNYQTh{IHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO|YYmsJGlEPTB;MD64OVgyQSEQvF2= M{jSXHNCVkeHUh?=
SW872 cell NFjFdXJIem:5dHigbY5pcWKrdHnvckBie3OjeR?= NG\6TJlKdmirYnn0bY9vKG:oIHj1cYFvKFOZOEeyJINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZktKEmFNUC9NE45PjR3ODFOwG0> M{DWXnNCVkeHUh?=
TE-12 cell MUDHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? NED6UFBKdmirYnn0bY9vKG:oIHj1cYFvKFSHLUGyJINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZktKEmFNUC9NE45QDh|MTFOwG0> M1XrbHNCVkeHUh?=
human HOP-62 cell MYrHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? MmnyTY5pcWKrdHnvckBw\iCqdX3hckBJV1BvNkKgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfUwhUUN3ME2wMlkyPTl7IN88US=> NXvIUnJ{W0GQR1XS
human NOS-1 cell NETJZlhIem:5dHigbY5pcWKrdHnvckBie3OjeR?= M3mzVWlvcGmkaYTpc44hd2ZiaIXtZY4hVk:VLUGgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfUwhUUN3ME2wMlk2ODR3IN88US=> NIryVGNUSU6JRWK=
human BL-41 cell NH\vO5hIem:5dHigbY5pcWKrdHnvckBie3OjeR?= MmWzTY5pcWKrdHnvckBw\iCqdX3hckBDVC12MTDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG|c3H5MEBKSzVyPUGuNFAxOTNizszN MXzTRW5ITVJ?
human TGBC24TKB cell NGTBXVlIem:5dHigbY5pcWKrdHnvckBie3OjeR?= NIfF[GNKdmirYnn0bY9vKG:oIHj1cYFvKFSJQlOyOHRMSiClZXzsJIdzd3e2aDDpckBiKGOnbHygeoli[mmuaYT5JIF{e2G7LDDJR|UxRTFwMEO4N|Eh|ryP M37UTnNCVkeHUh?=
human KGN cell MX7Hdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? MUPJcohq[mm2aX;uJI9nKGi3bXHuJGtIViClZXzsJIdzd3e2aDDpckBiKGOnbHygeoli[mmuaYT5JIF{e2G7LDDJR|UxRTFwMEWyNUDPxE1? MUPTRW5ITVJ?
human TK10 cell NHe3b21Iem:5dHigbY5pcWKrdHnvckBie3OjeR?= MmLPTY5pcWKrdHnvckBw\iCqdX3hckBVUzFyIHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO|YYmsJGlEPTB;MT6wPFQyQCEQvF2= M1nsV3NCVkeHUh?=
human GB-1 cell MWPHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? MUDJcohq[mm2aX;uJI9nKGi3bXHuJGdDNTFiY3XscEBoem:5dHigbY4h[SClZXzsJJZq[WKrbHn0fUBie3OjeTygTWM2OD1zLkG2NFY1KM7:TR?= NWK4XppXW0GQR1XS
human GCIY cell NUjNRXF1T3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= MWTJcohq[mm2aX;uJI9nKGi3bXHuJGdEUVliY3XscEBoem:5dHigbY4h[SClZXzsJJZq[WKrbHn0fUBie3OjeTygTWM2OD1zLkKzNFEh|ryP NEDIbYVUSU6JRWK=
human LXF-289 cell MVPHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? M4f0R2lvcGmkaYTpc44hd2ZiaIXtZY4hVFiILUK4PUBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NCCLQ{WwQVEvOjd{NU[g{txO NHnvb|BUSU6JRWK=
RL95-2 cell NI\uOWJIem:5dHigbY5pcWKrdHnvckBie3OjeR?= NF7RV2FKdmirYnn0bY9vKG:oIHj1cYFvKFKOOUWtNkBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NCCLQ{WwQVEvOzJ2M{[g{txO NF\hfHFUSU6JRWK=
human SW962 cell MlPDS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? MlXUTY5pcWKrdHnvckBw\iCqdX3hckBUXzl4MjDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG|c3H5MEBKSzVyPUGuN|M4PDJizszN M2rme3NCVkeHUh?=
human HT-144 cell M1zYV2dzd3e2aDDpcohq[mm2aX;uJIF{e2G7 NVfCcWFMUW6qaXLpeIlwdiCxZjDoeY1idiCKVD2xOFQh[2WubDDndo94fGhiaX6gZUBk\WyuII\pZYJqdGm2eTDhd5NigSxiSVO1NF0yNjR2NUG3JO6ddQ>? M2\VdHNCVkeHUh?=
human IST-SL2 cell M2LVUGdzd3e2aDDpcohq[mm2aX;uJIF{e2G7 MXfJcohq[mm2aX;uJI9nKGi3bXHuJGlUXC2VTEKgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfUwhUUN3ME2xMlQ4PDJzIN88US=> MVrTRW5ITVJ?
human NB6 cell MmnpS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? MmmwTY5pcWKrdHnvckBw\iCqdX3hckBPSjZiY3XscEBoem:5dHigbY4h[SClZXzsJJZq[WKrbHn0fUBie3OjeTygTWM2OD1zLk[5Olk5KM7:TR?= MlXLV2FPT0WU
human SF126 cell NUPITo5bT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= M1;mZ2lvcGmkaYTpc44hd2ZiaIXtZY4hW0ZzMk[gZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfUwhUUN3ME2xMlc{OTd6IN88US=> MlzWV2FPT0WU
human BOKU cell M2XWV2dzd3e2aDDpcohq[mm2aX;uJIF{e2G7 Mn3CTY5pcWKrdHnvckBw\iCqdX3hckBDV0uXIHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO|YYmsJGlEPTB;MT64NFUzPyEQvF2= NHnncoZUSU6JRWK=
human BB30-HNC cell NHLaS4tIem:5dHigbY5pcWKrdHnvckBie3OjeR?= M2TPUWlvcGmkaYTpc44hd2ZiaIXtZY4hSkJ|MD3IUmMh[2WubDDndo94fGhiaX6gZUBk\WyuII\pZYJqdGm2eTDhd5NigSxiSVO1NF0yNjh3NEeyJO69VQ>? MVrTRW5ITVJ?
human KLE cell MkTzS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? Mn:4TY5pcWKrdHnvckBw\iCqdX3hckBMVEViY3XscEBoem:5dHigbY4h[SClZXzsJJZq[WKrbHn0fUBie3OjeTygTWM2OD1zLki2NlMzKM7:TR?= MljzV2FPT0WU
human MLMA cell NXjPbXV[T3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= Mk\nTY5pcWKrdHnvckBw\iCqdX3hckBOVE2DIHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO|YYmsJGlEPTB;MT65NlMyKM7:TR?= MV;TRW5ITVJ?
human KINGS-1 cell MU\Hdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? Ml22TY5pcWKrdHnvckBw\iCqdX3hckBMUU6JUz2xJINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZktKEmFNUC9NU46Pjh7NzFOwG0> NX7QfWtmW0GQR1XS
human ES6 cell MknmS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? M13NTWlvcGmkaYTpc44hd2ZiaIXtZY4hTVN4IHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO|YYmsJGlEPTB;Mj6wOVQxOSEQvF2= NHzpTIxUSU6JRWK=
human SH-4 cell NW[y[m1zT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= NHTNVJVKdmirYnn0bY9vKG:oIHj1cYFvKFOKLUSgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfUwhUUN3ME2yMlEzODV3IN88US=> NY\nUGF5W0GQR1XS
human D-263MG cell Ml3OS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? NVrrZnk1UW6qaXLpeIlwdiCxZjDoeY1idiCGLUK2N21IKGOnbHyg[5Jwf3SqIHnuJIEh[2WubDD2bYFjcWyrdImgZZN{[XluIFnDOVA:Oi5{OEi1N{DPxE1? NGfzc3BUSU6JRWK=
human SF268 cell M4m3O2dzd3e2aDDpcohq[mm2aX;uJIF{e2G7 Mm[4TY5pcWKrdHnvckBw\iCqdX3hckBUTjJ4ODDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG|c3H5MEBKSzVyPUKuOFg3QDJizszN NWXKemY1W0GQR1XS
human NB17 cell NEjjNpdIem:5dHigbY5pcWKrdHnvckBie3OjeR?= NEnHUlFKdmirYnn0bY9vKG:oIHj1cYFvKE6EMUegZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfUwhUUN3ME2yMlYzQDd3IN88US=> MYXTRW5ITVJ?
human DMS-114 cell M1j0Smdzd3e2aDDpcohq[mm2aX;uJIF{e2G7 MmrRTY5pcWKrdHnvckBw\iCqdX3hckBFVVNvMUG0JINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZktKEmFNUC9Nk44QTB{MjFOwG0> NFrOcm5USU6JRWK=
MC116 cell M1jEWGdzd3e2aDDpcohq[mm2aX;uJIF{e2G7 MVTJcohq[mm2aX;uJI9nKGi3bXHuJG1EOTF4IHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO|YYmsJGlEPTB;Mj64OVcxPCEQvF2= NEPGUoZUSU6JRWK=
human NCI-H747 cell NGXyWolIem:5dHigbY5pcWKrdHnvckBie3OjeR?= NYLCPHJLUW6qaXLpeIlwdiCxZjDoeY1idiCQQ1mtTFc1PyClZXzsJIdzd3e2aDDpckBiKGOnbHygeoli[mmuaYT5JIF{e2G7LDDJR|UxRTVwN{SxOVkh|ryP MWrTRW5ITVJ?
human A388 cell MXnHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? Mnm2TY5pcWKrdHnvckBw\iCqdX3hckBCOzh6IHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO|YYmsJGlEPTB;MUSuOlc2QCEQvF2= NFP4W41USU6JRWK=

... Click to View More Cell Line Experimental Data

Protocol

Solubility (25°C)

In vitro DMSO 12 mg/mL warmed (21.1 mM)
Ethanol 6 mg/mL warmed (10.55 mM)
Water Insoluble
In vivo Add solvents to the product individually and in order(Data is from Selleck tests instead of citations):
5% DMSO+30% PEG 300+5% Tween 80+ddH2O
For best results, use promptly after mixing.
1mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 568.67
Formula

C32H36N6O4

CAS No. 837422-57-8
Storage powder
in solvent
Synonyms KIN001-112, KIN112

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Src Signaling Pathway Map

Related Src Products

Tags: buy WH-4-023 | WH-4-023 supplier | purchase WH-4-023 | WH-4-023 cost | WH-4-023 manufacturer | order WH-4-023 | WH-4-023 distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID